drugset / Trial / NCT00306891

Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)

NCT00306891

Phase 2 Completed 60 enrolled AstraZeneca
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine whether food has any effect on a single dose of Cediranib (AZD2171, Recentin™)followed by an assessment of the safety and tolerability of fixed daily dosing in comparison to varying dose levels on a patient-by-patient basis.

Timeline

Start
2006-06
Primary completion
2008-01
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cediranib Small molecule 30 mg Oral
Subject Cediranib Small molecule 45 mg Oral
Subject Cediranib Small molecule 90 mg Oral

Indications